Abstract
A biological marker (biomarker) is simply a molecule that indicates an alteration in physiology from the normal. For example, any specific molecular alteration of a cancer cell either on DNA, RNA, or protein level can be referred to as a molecular marker. A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. The topic of biomarkers has been discussed in a special report on this topic (Jain 2009f). The expression of a distinct gene can enable its identification in a tissue with none of the surrounding cells expressing the specific marker. Relation of biomarkers to other technologies and healthcare is shown in Fig. 3.1. Applications of biomarkers relevant to personalized medicine are: The biomarker would specifically and sensitively reflect a disease state and could be used for diagnosis, for predicting response to drug, and for disease monitoring during and following therapy. Biomarkers can be used as drug targets in drug development. Biomarkers might serve to integrate diagnostics and therapeutics.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Borovecki F, Lovrecic L, Zhou J et al (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington’s disease. Proc Natl Acad Sci USA 102:11023–11028
Jain KK (2009f) Biomarkers: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.
Kiernan UA (2008) Biomarker rediscovery in diagnostics. Expert Opin Mol Diagn 2:1391–1400
Maxwell PR, Flisiak R (2005) Changes in serological biomarkers of liver function and connective tissue turnover in chronic hepatitis B during lamivudine therapy. Biomarkers 10:475–84
Miller WL, Hartman KA, Burritt MF et al (2005) Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure. Clin Chem 51:569–577
Riegman PH, Morente MM, Betsou F et al (2008) Biobanking for better healthcare. Mol Oncol 2:213–222
Stenvinkel P, Karimi M, Johansson S et al (2007) Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease? J Intern Med 261:488–499
Wunder A, Tung CH, Muller-Ladner U et al (2004) In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 50:2459–2465
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jain, K.K. (2009). Role of Biomarkers in Personalized Medicine. In: Textbook of Personalized Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0769-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0769-1_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0768-4
Online ISBN: 978-1-4419-0769-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)